UNSPSC 51191909: Thiamine

This classification denotes a b vitamin with the molecular formula C12H17N4OS.Cl, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X66NSO3N35, chemically known as 67-03-8 (chloride, hcl) but generally known as thiamine, which bears US NIH Compound Identifier 1130. European Medicines Agency schedules Thiamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10969MIG. The term THIAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18).

UNSPSC 51191909 Thiamine is a Commodity code that in practice encompasses chemical supply procurement by state and local water utilities, health agencies, and cooperative purchasing alliances—though recent opportunities show significant scope mismatch, with active solicitations addressing sodium bisulfite for water treatment and multi-source pharmaceutical distribution rather than thiamine specifically. State and local buyers under this code include municipal water pollution control facilities, state departments of administration overseeing cooperative purchasing, and participating government health and institutional facilities across multiple jurisdictions. The work involves sourcing chemicals and pharmaceuticals to specification, managing vendor relationships with authorized wholesalers, certifying compliance with FDA and manufacturing standards, and ensuring insurance and bonding requirements are met.

Recent activity appears concentrated in the upper Midwest and Connecticut. The City of Meriden, Connecticut issued an IFB (solicitation B02715) for sodium bisulfite chemical supply to its Water Pollution Control Facility with a response deadline of July 29, 2026, requiring bidders to carry General Liability coverage of $1,000,000 to $2,000,000 and performance bonds. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a multi-award RFP for generic pharmaceuticals and OTC products with responses due March 26, 2026, covering participating state and local government facilities in Minnesota and Oregon; MMCAP requires vendors to maintain relationships with authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health, and Morris & Dickson Co., LLC), achieve cGMP and DSCSA compliance, and carry commercial general liability of $5,000,000 per occurrence, with pricing weighted at 75 percent of the evaluation.